Research funder · United States
U.S. Food and Drug Administration
Agency of the US Department of Health and Human Services
- Grants since 2016
- 5 518
- Awarded, last 5 years (where amounts are published)
- $632.7M
- Funded works, last 5 years
- 5 510
- Funded works, all time
- 26.5k
Grants
2024–2026 · cooperative agreement · U01
Development of a Qualification Plan for the Virtual Reality Functional Capacity Assessment Tool - Short List (VRFCAT-SLx) (DDT COA #000004)
Sonya Eremenco · Critical Path Institute
2024–2027 · cooperative agreement · U01
Continuing to Support and Enhance an Integrated Food Safety System Through Implementation of Program Standards, Data Sharing, Collaboration, and State Training and Equipment Grants.
Patrick Kennelly · National Association of County and City Health Officials
2024–2025 · cooperative agreement · U18
Building next-generation sequencing (NGS) capacity for One Health and antimicrobial stewardship projects An on-going case study of multidrug-resistant Salmonella in zoo mammals
Brianna Stenger · North Dakota State University
2024–2026 · cooperative agreement · U01
Measuring Digital Clinical Endpoints in Huntington's Disease (MEND-HD)
Jamie Lynn Adams · University of Rochester
2024–2025 · cooperative agreement · U01
DDT-BMQ-000054: Planning for biomarker qualification, implementation and dissemination for BMD as a surrogate biomarker in future osteoporosis treatment trials: the SABRE project
Dennis M Black · University of California, San Francisco
2024–2025 · cooperative agreement · U18
Assessing correlation between antimicrobial resistance genes and susceptibility phenotypes for Enterobacter cloacae complex isolates from the Vet-LIRN AMR monitoring program and clinical samples
Jianfa Bai · Kansas State University
2024–2028 · research · R01
Phase 2a/2b Study Emapalumab: A Window of Opportunity in Pediatric Aplastic Anemia
Joseph H Oved · Kettering University
2024–2026 · cooperative agreement · U18
Validation of quantative method for thiamine detection in animal feed, tissue and plasma
Kevin Roy Snekvik · Washington State University
2024–2027 · cooperative agreement · U01
Development of PBPK Model-Based Mechanistic IVIVCs for Long-Acting Injectable Suspensions
Diane Jane Burgess · University of Connecticut
2024–2026 · cooperative agreement · U01
ML-CFD-DEM Based Reduced Order Models (ROM) to Quantify Variability in Inhalers, Drugs, and Users for Evaluating Comparability of Generic OIDP Complex Products
Changjie Cai · Oklahoma State University
2024–2029 · cooperative agreement · U18
Controlling Histomonas meleagridis transmission in turkey flocks
Zhicheng Dou · Division Of Agriculture
2024–2025 · cooperative agreement · U01
Nitrosamines Forum to Advance Critical Translational Science (NA FACTS)
Connie L Jiang · Health and Environmental Sciences Institute
2024–2027 · cooperative agreement · U2F
A Coordinated National Approach to Supporting, Promoting, and Implementing FDA's Produce Safety Rule and the Produce Regulatory Program Standards
Joe Reardon · Nat'l Assn/state/depts/agricultu/res/fdn
2024–2029 · cooperative agreement · U18
UC Davis IGA Innovation Center
Trish Berger · University of California, Davis
2024–2025 · research · R01
Analytical method validation to detect and quantify tulathromycin residues in caprine liver
Patrick J Gorden · Iowa State University
2024–2029 · cooperative agreement · U01
Bridging Critical Data Gaps in Veterinary Medicine Via Artificial Intelligence and Advanced Large Language Models to Procure Real-Time Antibiotic Use Data in Livestock, Poultry and Companion Animals
Majid Jaberi-Douraki · Kansas State University
2024–2027 · research · R13
Forum on Neuroscience and Nervous System Disorders Proposal
Sheena Maria Posey Norris · National Academy of Sciences
2024–2029 · cooperative agreement · U01
A System Approach to Animal-Level Antimicrobial Use Monitoring in Dairy Cattle
Renata Ivanek Miojevic · Cornell University
2024–2028 · cooperative agreement · U01
Retinal biomarkers in monogenic vascular cognitive impairment and dementia
Jane S Paulsen · University of Wisconsin–Madison
2024–2029 · cooperative agreement · U18
The Building Resistance Against Viral Entities (BRAVE) Innovation Center
Peter Joseph Halfmann · University of Wisconsin–Madison
2024–2025 · cooperative agreement · U18
Mitigation of Highly pathogenic influenza (HPAI) in milk and dairy products
Samuel David Alcaine · Cornell University
2024–2025 · research · R13
Cannabis Regulators Association 2024 Annual Member Meeting: Furthering Regulatory Exchange and Collaboration
Gillian L Schauer · Cannabis Regulators Association
2024–2025 · cooperative agreement · U18
Impact of Antimicrobial Stewardship Resources on Companion Animal Veterinarians' Intention and Capability to Prescribe Fewer Antimicrobial Drugs
Erin Frey · North Carolina State University
2024–2028 · research · R13
Environmental Mutagenesis and Genomics Society (EMGS) Annual Meeting 2024-2028
Jeffrey C Bemis · Environmental Mutagenesis and Genomics Society
2024–2025 · research · R13
Society for Research on Nicotine and Tobacco 2024 Annual Meeting
Melissa D Blank · Society for Research on Nicotine and Tobacco
2024–2028 · research · R01
Defining pediatric intestinal failure natural history
Yaron Avitzur · University of Pittsburgh
2024–2028 · research · R01
Gene Therapy for LCA5-Assocated Inherited Retinal Degeneration: Extension to Pediatric Cohorts
Tomas S Aleman · University of Pennsylvania
2024–2028 · research · R01
SELVA: A Multicenter, Phase 3 Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 in the Treatment of Microcystic Lymphatic Malformations
Jeff Martini · Palvella Therapeutics, Inc.
2024–2027 · cooperative agreement · U01
Integrative proteogenomics for elucidation of tumor-specific cell surface proteomes in ultra-rare cancers
Alex Kentsis · Kettering University
2024–2029 · cooperative agreement · U01
Convener and Organizer of Activities and Engagements Related to Processes, Surveillance, and Policy Development of Medical Products for Ongoing Public Health Activities, U01 Clinical Trial Not Allowed
Marianne Hamilton Lopez · Duke University
2024–2027 · cooperative agreement · U01
Defining Actionable Opportunities in Malignant Phyllodes via Genomic Profiling
Laura Horst Rosenberger · Duke University
2024–2026 · cooperative agreement · U01
Maintenance of Human and Animal Food Rapid Response Team - Wisconsin
Troy S Sprecker · Wisconsin Department of Agriculture Trade and Consumer Protection
2024–2029 · cooperative agreement · U18
Antimicrobial Resistance Monitoring in Bacteria of Veterinary Significance
Cassandra Guarino · Cornell University
2024–2025 · cooperative agreement · U01
Advancing Health Equity Through Linguistic Inclusion in Clinical Trials
Luis R. Alvarez-Hernandez · University Of Connecticut Sch Of Med/dnt
2024–2028 · research · R01
Retinoblastoma Phase II Expanded Access Clinical Trial
Ricardo A Carvalho · 3T Ophthalmics (United States)
2024–2026 · cooperative agreement · U2F
Alabama Department of Public Health Maintaining Conformance of MFRPS
Mitzi Waldo · Alabama Department of Public Health
2024–2027 · cooperative agreement · U01
A human abuse potential study of kratom
Christopher D Verrico · Baylor College of Medicine
2024–2026 · research · R13
Workshop series to identify, discuss and develop recommendations for the optimal generation and use of in vitro assay data for tobacco product regulation
Rodger D Curren · Institute for In Vitro Sciences
2024–2027 · cooperative agreement · U01
Developing PBPK-model based mechanistic IVIVC for PLGA implants
Ming Hu · The University of Texas at Austin
2024–2027 · cooperative agreement · U01
From Bench to Bioequivalence: In Vitro Mechanistic Understanding of ASD Drug Products in Simulated Gastrointestinal Conditions
Maxime Le Merdy · Simulations Plus (United States)